Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes.

Vandromme M, Jun T, Perumalswami P, Dudley JT, Branch A, Li L.

Pac Symp Biocomput. 2020;25:91-102.

2.

The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability.

Salifou K, Ray S, Verrier L, Aguirrebengoa M, Trouche D, Panov KI, Vandromme M.

Nat Commun. 2016 Jan 5;7:10174. doi: 10.1038/ncomms10174.

3.

Intubation patterns and outcomes in patients with computed tomography-verified traumatic brain injury.

Vandromme MJ, Melton SM, Griffin R, McGwin G, Weinberg JA, Minor M, Rue LW 3rd, Kerby JD.

J Trauma. 2011 Dec;71(6):1615-9. doi: 10.1097/TA.0b013e31822a30a1.

PMID:
21841511
4.

Histone demethylases in chromatin cross-talks.

Verrier L, Vandromme M, Trouche D.

Biol Cell. 2011 Aug;103(8):381-401. doi: 10.1042/BC20110028. Review.

PMID:
21736555
5.

A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation.

Verrier L, Escaffit F, Chailleux C, Trouche D, Vandromme M.

PLoS Genet. 2011 Jun;7(6):e1001390. doi: 10.1371/journal.pgen.1001390. Epub 2011 Jun 2.

6.

Prospective identification of patients at risk for massive transfusion: an imprecise endeavor.

Vandromme MJ, Griffin RL, McGwin G Jr, Weinberg JA, Rue LW 3rd, Kerby JD.

Am Surg. 2011 Feb;77(2):155-61.

PMID:
21337871
7.

Image-guided methods for biopsy of suspicious breast lesions.

Vandromme MJ, Umphrey H, Krontiras H.

J Surg Oncol. 2011 Mar 15;103(4):299-305. doi: 10.1002/jso.21795. Review.

PMID:
21337562
8.

Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index.

Vandromme MJ, Griffin RL, Kerby JD, McGwin G Jr, Rue LW 3rd, Weinberg JA.

J Trauma. 2011 Feb;70(2):384-8; discussion 388-90. doi: 10.1097/TA.0b013e3182095a0a.

PMID:
21307738
9.

Duration of red cell storage influences mortality after trauma.

Weinberg JA, McGwin G Jr, Vandromme MJ, Marques MB, Melton SM, Reiff DA, Kerby JD, Rue LW 3rd.

J Trauma. 2010 Dec;69(6):1427-31; discussion 1431-2. doi: 10.1097/TA.0b013e3181fa0019.

10.

Effects of virtual reality simulator training method and observational learning on surgical performance.

Snyder CW, Vandromme MJ, Tyra SL, Porterfield JR Jr, Clements RH, Hawn MT.

World J Surg. 2011 Feb;35(2):245-52. doi: 10.1007/s00268-010-0861-1.

PMID:
21086125
11.

Retention of colonoscopy skills after virtual reality simulator training by independent and proctored methods.

Snyder CW, Vandromme MJ, Tyra SL, Hawn MT.

Am Surg. 2010 Jul;76(7):743-6.

PMID:
20698383
12.

Computed tomography identification of latent pseudoaneurysm after blunt splenic injury: pathology or technology?

Weinberg JA, Lockhart ME, Parmar AD, Griffin RL, Melton SM, Vandromme MJ, McGwin G Jr, Rue LW 3rd.

J Trauma. 2010 May;68(5):1112-6. doi: 10.1097/TA.0b013e3181d769fc.

PMID:
20453766
13.

Lactate is a better predictor than systolic blood pressure for determining blood requirement and mortality: could prehospital measures improve trauma triage?

Vandromme MJ, Griffin RL, Weinberg JA, Rue LW 3rd, Kerby JD.

J Am Coll Surg. 2010 May;210(5):861-7, 867-9. doi: 10.1016/j.jamcollsurg.2010.01.012.

PMID:
20421067
14.

A second look at the fresh frozen plasma: packed red blood cell ratio in massive transfusion protocols.

Vandromme MJ, Snyder CW, McGwin G Jr, Weinberg JA, Kerby JD.

J Am Coll Surg. 2010 Jan;210(1):117; author reply 117-8. doi: 10.1016/j.jamcollsurg.2009.09.036. No abstract available.

PMID:
20123343
15.

Management of colon wounds in the setting of damage control laparotomy: a cautionary tale.

Weinberg JA, Griffin RL, Vandromme MJ, Melton SM, George RL, Reiff DA, Kerby JD, Rue LW 3rd.

J Trauma. 2009 Nov;67(5):929-35. doi: 10.1097/TA.0b013e3181991ab0.

PMID:
19901650
16.

Proficiency-based laparoscopic and endoscopic training with virtual reality simulators: a comparison of proctored and independent approaches.

Snyder CW, Vandromme MJ, Tyra SL, Hawn MT.

J Surg Educ. 2009 Jul-Aug;66(4):201-7. doi: 10.1016/j.jsurg.2009.07.007.

PMID:
19896624
17.

Blood transfusion in the critically ill: does storage age matter?

Vandromme MJ, McGwin G Jr, Weinberg JA.

Scand J Trauma Resusc Emerg Med. 2009 Aug 13;17:35. doi: 10.1186/1757-7241-17-35. Review.

18.

Transfusion and pneumonia in the trauma intensive care unit: an examination of the temporal relationship.

Vandromme MJ, McGwin G Jr, Marques MB, Kerby JD, Rue LW 3rd, Weinberg JA.

J Trauma. 2009 Jul;67(1):97-101. doi: 10.1097/TA.0b013e3181a5a8f9.

PMID:
19590316
19.

Sodium nitrite therapy attenuates the hypertensive effects of HBOC-201 via nitrite reduction.

Rodriguez C, Vitturi DA, He J, Vandromme M, Brandon A, Hutchings A, Rue LW 3rd, Kerby JD, Patel RP.

Biochem J. 2009 Aug 27;422(3):423-32. doi: 10.1042/BJ20090735.

20.

Progesterone in traumatic brain injury: time to move on to phase III trials.

Vandromme M, Melton SM, Kerby JD.

Crit Care. 2008;12(3):153. doi: 10.1186/cc6899. Epub 2008 May 29.

21.

Binding of the retinoblastoma protein is not the determinant for stable repression of some E2F-regulated promoters in muscle cells.

Vandromme M, Chailleux C, Escaffit F, Trouche D.

Mol Cancer Res. 2008 Mar;6(3):418-25. doi: 10.1158/1541-7786.MCR-07-0381. Epub 2008 Feb 22.

22.

Postsynaptic chromatin is under neural control at the neuromuscular junction.

Ravel-Chapuis A, Vandromme M, Thomas JL, Schaeffer L.

EMBO J. 2007 Feb 21;26(4):1117-28. Epub 2007 Feb 15.

23.

Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression.

Tyteca S, Vandromme M, Legube G, Chevillard-Briet M, Trouche D.

EMBO J. 2006 Apr 19;25(8):1680-9. Epub 2006 Apr 6.

24.

Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy.

Rochat A, Fernandez A, Vandromme M, Molès JP, Bouschet T, Carnac G, Lamb NJ.

Mol Biol Cell. 2004 Oct;15(10):4544-55. Epub 2004 Jul 28.

25.

Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.

Safi A, Vandromme M, Caussanel S, Valdacci L, Baas D, Vidal M, Brun G, Schaeffer L, Goillot E.

Mol Cell Biol. 2004 Feb;24(3):1245-55.

26.

Conditional gene knock-down by CRE-dependent short interfering RNAs.

Fritsch L, Martinez LA, Sekhri R, Naguibneva I, Gérard M, Vandromme M, Schaeffer L, Harel-Bellan A.

EMBO Rep. 2004 Feb;5(2):178-82. Epub 2004 Jan 9.

27.

Synapse-specific gene expression at the neuromuscular junction.

Méjat A, Ravel-Chapuis A, Vandromme M, Schaeffer L.

Ann N Y Acad Sci. 2003 Sep;998:53-65. Review.

PMID:
14592863
28.

Localization of the RNA-binding proteins Staufen1 and Staufen2 at the mammalian neuromuscular junction.

Bélanger G, Stocksley MA, Vandromme M, Schaeffer L, Furic L, DesGroseillers L, Jasmin BJ.

J Neurochem. 2003 Aug;86(3):669-77.

29.

MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration.

L'honore A, Lamb NJ, Vandromme M, Turowski P, Carnac G, Fernandez A.

Mol Biol Cell. 2003 May;14(5):2151-62. Epub 2003 Jan 26.

30.

Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY.

Gilthorpe J, Vandromme M, Brend T, Gutman A, Summerbell D, Totty N, Rigby PW.

Development. 2002 Aug;129(16):3887-99.

32.

Protein kinase B beta/Akt2 plays a specific role in muscle differentiation.

Vandromme M, Rochat A, Meier R, Carnac G, Besser D, Hemmings BA, Fernandez A, Lamb NJ.

J Biol Chem. 2001 Mar 16;276(11):8173-9. Epub 2000 Nov 21.

33.

Muscle differentiation is antagonized by SOX15, a new member of the SOX protein family.

Béranger F, Méjean C, Moniot B, Berta P, Vandromme M.

J Biol Chem. 2000 May 26;275(21):16103-9.

34.

cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Kitzmann M, Vandromme M, Schaeffer V, Carnac G, Labbé JC, Lamb N, Fernandez A.

Mol Cell Biol. 1999 Apr;19(4):3167-76.

35.

The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.

Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ, Fernandez A.

J Cell Biol. 1998 Sep 21;142(6):1447-59.

36.

Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells.

Lazaro JB, Kitzmann M, Poul MA, Vandromme M, Lamb NJ, Fernandez A.

J Cell Sci. 1997 May;110 ( Pt 10):1251-60.

37.

Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.

Lenormand JL, Benayoun B, Guillier M, Vandromme M, Leibovitch MP, Leibovitch SA.

Mol Cell Biol. 1997 Feb;17(2):584-93.

38.

Growth and differentiation of C2 myogenic cells are dependent on serum response factor.

Soulez M, Rouviere CG, Chafey P, Hentzen D, Vandromme M, Lautredou N, Lamb N, Kahn A, Tuil D.

Mol Cell Biol. 1996 Nov;16(11):6065-74.

39.

Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts.

Gauthier-Rouviere C, Vandromme M, Tuil D, Lautredou N, Morris M, Soulez M, Kahn A, Fernandez A, Lamb N.

Mol Biol Cell. 1996 May;7(5):719-29.

40.

Regulation of transcription factor localization: fine-tuning of gene expression.

Vandromme M, Gauthier-Rouvière C, Lamb N, Fernandez A.

Trends Biochem Sci. 1996 Feb;21(2):59-64. Review.

PMID:
8851662
41.

Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and can function independently.

Vandromme M, Cavadore JC, Bonnieu A, Froeschlé A, Lamb N, Fernandez A.

Proc Natl Acad Sci U S A. 1995 May 9;92(10):4646-50.

42.

The serum response factor nuclear localization signal: general implications for cyclic AMP-dependent protein kinase activity in control of nuclear translocation.

Gauthier-Rouvière C, Vandromme M, Lautredou N, Cai QQ, Girard F, Fernandez A, Lamb N.

Mol Cell Biol. 1995 Jan;15(1):433-44.

43.

Nuclear import of the myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD.

Vandromme M, Carnac G, Gauthier-Rouvière C, Fesquet D, Lamb N, Fernandez A.

J Cell Sci. 1994 Feb;107 ( Pt 2):613-20.

44.

Overexpression of c-erbA proto-oncogene enhances myogenic differentiation.

Carnac G, Albagli-Curiel O, Desclozeaux M, Vandromme M, Glineur C, Bègue A, Laudet V, Bonnieu A.

Oncogene. 1993 Nov;8(11):3103-10.

PMID:
8414512
45.

Serum-induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells.

Albagli-Curiel O, Carnac G, Vandromme M, Vincent S, Crépieux P, Bonnieu A.

Differentiation. 1993 Mar;52(3):201-10.

PMID:
8387038
46.

Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines.

Vandromme M, Gauthier-Rouvière C, Carnac G, Lamb N, Fernandez A.

J Cell Biol. 1992 Sep;118(6):1489-500.

47.

3,5,3'-Triiodothyronine positively regulates both MyoD1 gene transcription and terminal differentiation in C2 myoblasts.

Carnac G, Albagli-Curiel O, Vandromme M, Pinset C, Montarras D, Laudet V, Bonnieu A.

Mol Endocrinol. 1992 Aug;6(8):1185-94.

PMID:
1406697
48.

Supplemental Content

Loading ...
Support Center